Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.
Saved in:
| Title: | Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. |
|---|---|
| Authors: | Zhang, Jian1,2 (AUTHOR) syner2000@163.com, Meng, Yanchun1,2 (AUTHOR), Wang, Biyun1,2 (AUTHOR), Wu, Xinhong3 (AUTHOR), Zheng, Hongmei3 (AUTHOR), Hu, Jing4 (AUTHOR), Liu, Wei4 (AUTHOR), Chen, Wenyan5 (AUTHOR), Wang, Leiping1,2 (AUTHOR), Cao, Jun1,2 (AUTHOR), Tao, Zhonghua1,2 (AUTHOR), Li, Ting1,2 (AUTHOR), Ni, Sujie6 (AUTHOR), Yu, Zhengyan7 (AUTHOR), Sun, Lichun4 (AUTHOR), Wang, Yun5 (AUTHOR), Peng, Qiang5 (AUTHOR), Wang, Song7 (AUTHOR), Hu, Xin8 (AUTHOR), Wang, Jianfei9 (AUTHOR) |
| Source: | PLoS Medicine. 7/31/2025, Vol. 22 Issue 7, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 187070418 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhang%2C+Jian%22">Zhang, Jian</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> syner2000@163.com</i><br /><searchLink fieldCode="AR" term="%22Meng%2C+Yanchun%22">Meng, Yanchun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Biyun%22">Wang, Biyun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Xinhong%22">Wu, Xinhong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Hongmei%22">Zheng, Hongmei</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Jing%22">Hu, Jing</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Wei%22">Liu, Wei</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Wenyan%22">Chen, Wenyan</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Leiping%22">Wang, Leiping</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Jun%22">Cao, Jun</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tao%2C+Zhonghua%22">Tao, Zhonghua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Ting%22">Li, Ting</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ni%2C+Sujie%22">Ni, Sujie</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Zhengyan%22">Yu, Zhengyan</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Lichun%22">Sun, Lichun</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yun%22">Wang, Yun</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Qiang%22">Peng, Qiang</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Song%22">Wang, Song</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Xin%22">Hu, Xin</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jianfei%22">Wang, Jianfei</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+Medicine%22">PLoS Medicine</searchLink>. 7/31/2025, Vol. 22 Issue 7, p1-17. 17p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=187070418 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pmed.1004669 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 1 Titles: – TitleFull: Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang, Jian – PersonEntity: Name: NameFull: Meng, Yanchun – PersonEntity: Name: NameFull: Wang, Biyun – PersonEntity: Name: NameFull: Wu, Xinhong – PersonEntity: Name: NameFull: Zheng, Hongmei – PersonEntity: Name: NameFull: Hu, Jing – PersonEntity: Name: NameFull: Liu, Wei – PersonEntity: Name: NameFull: Chen, Wenyan – PersonEntity: Name: NameFull: Wang, Leiping – PersonEntity: Name: NameFull: Cao, Jun – PersonEntity: Name: NameFull: Tao, Zhonghua – PersonEntity: Name: NameFull: Li, Ting – PersonEntity: Name: NameFull: Ni, Sujie – PersonEntity: Name: NameFull: Yu, Zhengyan – PersonEntity: Name: NameFull: Sun, Lichun – PersonEntity: Name: NameFull: Wang, Yun – PersonEntity: Name: NameFull: Peng, Qiang – PersonEntity: Name: NameFull: Wang, Song – PersonEntity: Name: NameFull: Hu, Xin – PersonEntity: Name: NameFull: Wang, Jianfei IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 07 Text: 7/31/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 15491277 Numbering: – Type: volume Value: 22 – Type: issue Value: 7 Titles: – TitleFull: PLoS Medicine Type: main |
| ResultId | 1 |